Correlation Between Cannara Biotech and Biosyent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Biosyent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Biosyent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Biosyent, you can compare the effects of market volatilities on Cannara Biotech and Biosyent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Biosyent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Biosyent.

Diversification Opportunities for Cannara Biotech and Biosyent

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cannara and Biosyent is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Biosyent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosyent and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Biosyent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosyent has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Biosyent go up and down completely randomly.

Pair Corralation between Cannara Biotech and Biosyent

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 3.08 times more return on investment than Biosyent. However, Cannara Biotech is 3.08 times more volatile than Biosyent. It trades about 0.08 of its potential returns per unit of risk. Biosyent is currently generating about 0.06 per unit of risk. If you would invest  62.00  in Cannara Biotech on September 23, 2024 and sell it today you would earn a total of  13.00  from holding Cannara Biotech or generate 20.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cannara Biotech  vs.  Biosyent

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
Biosyent 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Biosyent may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cannara Biotech and Biosyent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and Biosyent

The main advantage of trading using opposite Cannara Biotech and Biosyent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Biosyent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosyent will offset losses from the drop in Biosyent's long position.
The idea behind Cannara Biotech and Biosyent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules